SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549


                           ---------------------------


                                   FORM 8-K/A


                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934



Date of Report                             April 2, 2003
(Date of earliest event reported)         --------------------------------------

                           MedicaLogic/Medscape, Inc.
               (Exact name of registrant as specified in charter)


                         


 Oregon                           000-28285                93-0890696
- --------------------------------------------------------------------------------
 (State or other            (Commission file              (IRS employer
 jurisdiction of                number)                 identification no.)
 incorporation)




                           20540 NW Evergreen Parkway
                             Hillsboro, Oregon 97124
- --------------------------------------------------------------------------------
                    (Address of principal executive offices)


Registrant's telephone number, including area code       (503) 531-7000
                                                    ----------------------------

                                 Not applicable
- --------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)





Item 5.  Other Events

     On January 24, 2002,  MedicaLogic/Medscape,  Inc. (the  "Company")  and its
five United  States  subsidiaries  filed a  voluntary  petition  for  bankruptcy
protection  (collectively,  the "Bankruptcy Cases") under Chapter 11 of the U.S.
Bankruptcy  Code (the  "Code") in the  United  States  Bankruptcy  Court for the
District  of  Delaware  (the  "Bankruptcy  Court").  The  Bankruptcy  Cases were
assigned to the Honorable Judge Peter J. Walsh and are jointly  administered and
coordinated  under Case Numbers 02 - 10253 (PJW)  through 02 - 10258  (PJW).  In
addition  to  the  Company,  the  filing  entities  were  MSCP  Holdings,  Inc.,
MedicaLogic  Enterprises,  Inc., MedicaLogic  Pennsylvania,  LLC, MedicaLogic of
Texas, Inc. and MedicaLogic  Texas, L.P.  (collectively,  with the Company,  the
"Debtors").

     On November 22, 2002,  the Debtors  filed a Joint Plan of  Liquidation  and
related  Disclosure  Statement in the Bankruptcy  Court pursuant to the Code. On
December 20, 2003,  the Debtors filed a First Amended Joint Plan of  Liquidation
(the "Plan") and related First Amended  Disclosure  Statement  (the  "Disclosure
Statement"),  copies of which are  attached  hereto as  Exhibit  2.1.  The Court
confirmed  the Plan on March 3, 2003.  On April 3, 2003,  the Debtors filed with
the Bankruptcy Court a Notice of (1) Entry of Confirmation Order, (2) Occurrence
of Effective Date, and (3) Important Bar Dates  announcing,  among other things,
that the effective date (the "Effective  Date") of the Plan occurred on April 2,
2003 (the "Notice"). The Notice is attached hereto as Exhibit 99.1.

     As described more fully in the Plan and Disclosure  Statement,  the Debtors
have no  business  operations,  and will not  initiate  or resume  any  business
operations in the future.  Therefore,  the Plan provides for the distribution of
the Debtors'  estates,  which  consist  primarily  of proceeds  from the sale of
substantially  all of their  assets  to  certain  third  parties  as  previously
disclosed and described by the Debtors on Form 8-K, dated August 29, 2001,  Form
8-K,  dated January 10, 2002,  and Form 8-K,  dated April 9, 2002.  The proceeds
will be distributed  through a liquidating  trust (the "Trust") to creditors and
equity  interest  holders  pursuant to the  priorities set forth in the Code, as
described  more fully in the Plan and  Disclosure  Statement.  On the  Effective
Date,  the Trust was  established  and acquired all of the Debtors'  assets (the
"Trust  Property")  and  assumed  all of the  Debtors'  liabilities.  The  Trust
Property will be distributed  in accordance  with the provisions of the Plan and
the Trust  Agreement,  a copy of which is attached  hereto as Exhibit  99.2,  as
promptly and efficiently as is practicable.

     Pursuant to the Plan,  all preferred  stock and common stock of the Company
were canceled on the Effective Date.

     On or about  April 11,  2003,  the Trustee  appointed  under the Plan began
making distributions that will total approximately $20,020,000 to all holders of
allowed preferred equity interests. As required by the Plan,  distributions were
to be  made  to  holders  of  allowed  preferred  equity  interests  which  were
authorized,  issued and  outstanding  prior to  commencement  of the  Bankruptcy
Cases.  These holders  received  distributions  equal to their preferred  equity
redemption price.

     Pursuant to the Plan,  distributions  are to be made only to allowed common
equity  interests that (a) were registered or listed as of December 20, 2002, in
a stock  register  maintained  by or on behalf of the Company and (b) either (i)
have not been the subject of any  objection  or (ii) have been  allowed (A) by a
final  order of the  Bankruptcy  Court or (B)  pursuant  to the  Plan.  The Plan
requires that these holders  receive a pro rata share of surplus Trust  Property
in accordance with the priority set forth in Article VII of the Plan.

     The  foregoing  summary of the Plan does not purport to be complete  and is
qualified in its entirety by reference to the Plan, which is incorporated herein
by reference.


     Item 7. Financial Statements and Exhibits.

     (c) Exhibits

================================================================================

     2.1    First Amended Joint Plan of Liquidation and related First Amended
            Disclosure Statement (filed as Exhibit 2.1 on Form 8-K, dated March
            18, 2003, and incorporated herein by reference).

    99.1    Notice of (1) Entry of Confirmation Order, (2) Occurrence of
            Effective Date, and (3) Important Bar Dates (filed as Exhibit 99.1
            on Form 8-K, dated April 8, 2003, and incorporated herein by
            reference).

    99.2    Trust Agreement, between the Debtors and Walker, Truesdell, Radick &
            Assoc., as trustee (filed as Exhibit 99.1 on Form 8-K, dated March
            18, 2003, and incorporated herein by reference).






                                    SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  April 16, 2003



                           MEDICALOGIC/MEDSCAPE, INC.


                            By: /s/ Hobart G. Truesdell
                                ---------------------------------
                                Name:  Hobart G. Truesdell
                                Title: Trustee





                                  EXHIBIT INDEX
================================================================================

     2.1    First Amended Joint Plan of Liquidation and related First Amended
            Disclosure Statement (filed as Exhibit 2.1 on Form 8-K, dated March
            18, 2003, and incorporated herein by reference).

    99.1    Notice of (1) Entry of Confirmation Order, (2) Occurrence of
            Effective Date, and (3) Important Bar Dates (filed as Exhibit 99.1
            on Form 8-K, dated April 8, 2003, and incorporated herein by
            reference).

    99.2    Trust Agreement, between the Debtors and Walker, Truesdell, Radick &
            Assoc., as trustee (filed as Exhibit 99.1 on Form 8-K, dated March
            18, 2003, and incorporated herein by reference).